Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
LLJEFFY tribute coin takes a 40% tumble after Zerebro founder was found alive at home

LLJEFFY tribute coin takes a 40% tumble after Zerebro founder was found alive at home

Crypto.NewsCrypto.News2025/05/08 16:00
By:By Trisha Husada

Zerebro co-founder Jeffy Yu was found alive in his parents’ home after evidently faking his suicide on a pump.fun livestream. As a result, his tribute meme coin LLJEFFY has fallen by 40%.

According to a report by local news outlet The San Francisco Standard, Jeffy Yu was confirmed to be alive and living in his parents’ home, five days after the 23-year-old crypto mogul seemingly took his own life on a livestream.

On-chain traders have speculated that Yu faked his own death as a way to depart from the crypto space. Especially after Yu’s obituary on the memorial platform, Legacy was removed a few days after it was published. Not only that, on-chain activity shows that there have been multiple transactions linked to Yu’s wallet after his alleged death.

On May 9, a reporter from the San Francisco Standard confirmed that Yu was not dead. Instead, he had been living in a two-story home with his parents. Yu declined to provide any commentary about the false reports of his death and how he benefited from it. However, the Zerebro ( ZEREBRO ) founder said that he would be moving his parents out of the home within a week due to fearing that other people would be able to track down his whereabouts.

“I’ve been doxxed. I’ve been harassed. If you can find me, other people can find me,” said Yu.

LLJEFFY tribute coin takes a 40% tumble after Zerebro founder was found alive at home image 0 Price chart for LLJEFFY, Zerebro co-founder Jeffy Yu’s legacy meme coin, May 9, 2025 | Source: DEX Screener

According to DEX Screener , the Solana ( SOL )-based meme coin LLJEFFY, created to honour Yu’s legacy, has fallen more than 40% following the news of Yu being alive. A far cry from its previous high when the token skyrocketed as high as 2,115% after news of Yu’s livestreamed suicide began to circulate. At the moment, the token has accumulated a market cap of $2.1 million.

“If you’re reading this, it’s because my 72-hour deadman’s switch triggered, so I’m not here, at least physically,” said the Zerebro co-founder in a scheduled blog post linked to the meme coin.

“This is a legacoin, my final art piece. $LLJEFFY,” he wrote.

On the other hand, Yu’s original staple token, ZEREBRO, has been on the rise. In the past 24 hours of trading, the token has gone up by 22.3%. It is currently valued at $0.048. In the past few days the token has also suffered a similar downfall to its “legacoin” counterpart, dropping by nearly 10% in the past week and declining by 34.8% in the past two weeks.

LLJEFFY tribute coin takes a 40% tumble after Zerebro founder was found alive at home image 1 Price chart for ZEREBRO in the past few days of trading, May 9, 2025 | Source: crypto.news

Controversy surrounding Zerebro founder Jeffy Yu’s ‘suicide’

On May 4, Zerebro co-founder Jeffy Yu was thought to have committed suicide. A video broadcast on meme coin launch platform Pump.fun showed Yu smoking a cigarette before shooting himself in the neck. The video was then shared multiple times on social media platform X.

Two days later, Yu’s obituary was published on the memorial platform Legacy. However, many traders suspected Yu had faked his own death after on-chain data showed that his wallet was still actively making transactions.

Analytics platforms like Bubblemaps and Lookonchain revealed that the LLJEFFY deployer and associated wallets were actively trading and burning tokens after Yu’ alleged death. Not only that, but an unverified letter was found indicating that his death had been staged.

Allegedly written by Yu, the letter stated that the Zerebro founder had faked his death as he believed it was the “only viable exit from persistent harassment, blackmail, and threats.”

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

U.S. non-farm payrolls surge by 165,000 in October, far exceeding expectations! Unemployment rate unexpectedly drops to 4.1%, December rate hike expectations intensify

In October, US non-farm payrolls increased by 165,000, which is 2.5 times the Wall Street median forecast of 65,000 and represents an exceptionally strong deviation of about 5 standard deviations, exceeding the upper limit of all institutional forecast ranges. The unemployment rate unexpectedly fell from 4.2% to 4.1%, while the market had expected it to remain unchanged; average hourly wages also accelerated year-on-year growth to 3.1%. Meanwhile, the previous two months' non-farm payrolls were revised upwards by a total of 84,000. Following the release of the data, the yield on 2-year US Treasury bonds rose by 7 basis points, and the pricing of the probability of a Fed rate hike in December climbed to 70%.

华尔街见闻•2026/11/06 15:01

AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

华尔街见闻•2026/11/06 13:42
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight

Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.

华尔街见闻•2026/11/06 13:23